Could cause temporary or reversible harm; serious harm is unlikely.
cGMP deviations
| Distributed by / for | Ultra Seal Corporation |
| NDC | 42961-112-03 |
| Full product label | Cold Relief (acetaminophen 250 mg, guaifenesin 200mg, phenylephrine HCl 5 mg) 2 tablets per packet, Mfd. for First Aid Direct, Mason, OH 45040, NDC 42961-112-03 |
| Recalling firm | Ultra Seal Corporation |
| Distribution | Nationwide within the United States |
| Quantity | 7,858,690 packets |
| Recall initiated | 2022-01-24 |
| Report date | 2022-02-09 |
| Recall completed | 2023-10-16 |
| Recall number | D-0483-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | New Paltz NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗